The KUVAN Co-pay Assistance Program provides financial assistance to eligible patients. It covers out-of-pocket costs associated with co-pay costs for KUVAN® (sapropterin dihydrochloride) prescriptions for eligible participants, up to the annual maximum of $14,000, for as long as the patient remains eligible.
The KUVAN Co-pay Assistance Program applies to co-pay costs related to KUVAN only, and will not cover out-of-pocket expenses for KUVAN beyond the annual maximum. It will also not cover your insurance premiums, transportation costs for clinic visits, or any co-pays related to clinic visits or lab tests.
To be eligible for the KUVAN Co-pay Assistance Program, you must have a prescription for KUVAN and be a resident of one of the 50 U.S. states or Puerto Rico. Additionally, the program is valid for commercially insured patients only. This means you must not be insured by a publicly funded health program such as Medicare, Medicaid, Veterans Affairs (VA), the Department of Defense (DoD or TRICARE), or any similar state-funded or federally funded program such as state pharmacy assistance programs. This program is subject to termination or modification at any time.